David Priest to Liver Neoplasms, Experimental
This is a "connection" page, showing publications David Priest has written about Liver Neoplasms, Experimental.
Connection Strength
0.230
-
The role of cellular folates in the enhancement of activity of the thymidylate synthase inhibitor 10-propargyl-5,8-dideazafolate against hepatoma cells in vitro by inhibitors of dihydrofolate reductase. J Biol Chem. 1989 Jun 25; 264(18):10685-92.
Score: 0.080
-
Response of mouse hepatoma cell methylenetetrahydrofolate polyglutamates to folate deprivation. Biochim Biophys Acta. 1983 Apr 20; 756(3):253-7.
Score: 0.052
-
Increased thymidylate synthetase in 5-fluorodeoxyuridine resistant cultured hepatoma cells. Biochem Pharmacol. 1980 Jun 01; 29(11):1549-53.
Score: 0.043
-
The enhancement of the activity of 10-propargyl-5,8-dideazafolate and 5,10-dideazatetrahydrofolate by inhibitors of dihydrofolate reductase. Adv Enzyme Regul. 1989; 28:13-21.
Score: 0.019
-
The role of folylpolyglutamate synthetase and gamma-glutamyl hydrolase in altering cellular folyl- and antifolylpolyglutamates. Adv Enzyme Regul. 1987; 26:147-55.
Score: 0.017
-
Cell cycle patterns of thymidylate synthetase and 5,10-methylenetetrahydrofolate polyglutamates in cultured mouse hepatoma cells. Experientia. 1982 Jan 15; 38(1):88-9.
Score: 0.012
-
Inhibition of mammalian thymidylate synthase by 10-formyltetrahydropteroylpolyglutamate. Arch Biochem Biophys. 1991 Jan; 284(1):219-22.
Score: 0.006